SEATTLE--(BUSINESS WIRE)--LifeSpan BioSciences, Inc., a leading antibody company specializing in immunohistochemistry and antibodies to drug target proteins, today announced a multi-year agreement with Roche for a subscription to LifeSpan’s DrugTarget DatabaseTM.
